DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lencioni R, Llovet JM, Han G , et al.
Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.
. [Abstract LBA154]
J Clin Oncol 2012; 30 (suppl)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.